Skip to main content

Early Myelosuppression Secondary to Linezolid Use in the Context of Hematologic Malignancy Cover

.blurhash-client-img { display: none !important; }

Early Myelosuppression Secondary to Linezolid Use in the Context of Hematologic Malignancy

Forum of Clinical Oncology

By: Yi-Lun Wang, Wan-Ju Lee and Tang-Her Jaing

Open Access

|Jul 2026

Articles in this issue

DOI: https://doi.org/10.2478/fco-2024-0029 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X

Journal RSS Feed

Language: English

Submitted on: May 10, 2025

|

Accepted on: Dec 8, 2025

|

Published on: Jul 14, 2026

Published by: Helenic Society of Medical Oncology

In partnership with: Paradigm Publishing Services

Keywords:

myelosuppression,

hematologic malignancy

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology

© 2026 Yi-Lun Wang, Wan-Ju Lee, Tang-Her Jaing, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.